pqe250Recently recognized as a Great Place to Work in the US for the second consecutive year, PQE Group, the woman-owned global consulting company, announces its mission towards innovation in the development of therapies for women’s health challenges.

A year after the foundation of GQC, an internal start-up of the Group focused on medical cannabis therapy solutions, Gilda D’Incerti - CEO and Founder of the company – is now dedicating her interest to FemTech (Female Technology) and the so-called SHEconomy: these primary market trends forecast tremendous growth in terms of profit and growth in the next decade, accelerating drug development for women’s health and well-being.

For the above reason and to better support the clinical operations in this market niche, PQE Group is formally entering the early development stages of new medicine discoveries by launching its own CRO (Clinical Research Organization), named ReSQ-UP, which will be fully dedicated to the execution of observational studies, pre- and post-marketing clinical investigations, and interventional clinical trials (Phase I and II) on innovative products belonging to the sector of women’s health and mainly covering new biotech, medical device and medical cannabis-based products.

This new medical arm of PQE Group will be managed by Doctor Moshe Hod, the newly appointed Chief Medical Advisor and part of the PQE Advisory Board. Dr. Hod is a Professor of Obstetrics and Gynecology at the Faculty of Medicine, Tel-Aviv University, Israel, and he is a member and the past Chair of the International Federation of Obstetrics and Gynecology (FIGO) Pregnancy and Non Communicable Disease  Committee (PNCDC) and a past member of FIGO’s Board of Directors.

If you would like to learn more about these market trends and join PQE Group in the FemTech revolution, come and meet PQE Group on its next online event, “FemTech Next: Roadmap to Business Resilience” on June 20th at 3:00 pm (CET) on the zoom platform. Moderated by Thomas Carganico, PQE Group’s VP of Strategic Development & Partner, and hosted by PQE Group CEO & Founder Gilda D’Incerti and Dr. Moshe Hod, the live event will welcome global speakers Reenita Das, Partner & SVP of Lifesciences at Frost & Sullivan, Keren Leshem, CEO at OCON Therapeutics, and Anne Kihara, President elect at FIGO.

Click here to book your presence now: https://webinar.pqegroup.com/femtech-next